News & Updates

Progressive resistant training (PRT) does not seem to work better than neuromuscular exercise (NEMEX) for easing hip pain and improving functional performance or hip-related quality of life (QoL) in patients with hip osteoarthritis (OA), reports a recent study.

In the phase II dose-ranging STRIDE trial presented at AAD 2024, ESK-001, a highly-selective and potentially best-in-class allosteric tyrosine kinase 2 (TYK2) inhibitor, demonstrated favourable efficacy and safety signals for the treatment of adults with moderate-to-severe plaque psoriasis.

Older age and female sex are some of the factors associated with early-onset interstitial lung disease (ILD) in rheumatoid arthritis (RA), reveals a study.

Breakthrough COVID-19 is not uncommon following pre-exposure prophylaxis (PrEP) with tixagevimab/cilgavimab among patients with systemic autoimmune rheumatic diseases (SARDs), reports a recent study. However, most of the infections in this high-risk population are not severe.